EDGAR Filing Documents for 0001193125-12-222337

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-12-222337

Filing Date

2012-05-09

Accepted

2012-05-09 16:57:04

Documents

Period of Report

2012-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d345387d10q.htm	10-Q	601631
2	FORM OF INDEMNIFICATION AGREEMENT WITH CERTAIN DIRECTORS AND EXECUTIVE OFFICERS	d345387dex101.htm	EX-10.1	67660
3	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED UNDER RULE 13A-14(A)	d345387dex311.htm	EX-31.1	8604
4	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED UNDER RULE 13A-14(A)	d345387dex312.htm	EX-31.2	8455
5	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER	d345387dex321.htm	EX-32.1	5893
	Complete submission text file	0001193125-12-222337.txt		2307174

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	avnr-20120331.xml	EX-101.INS	283930
7	XBRL TAXONOMY EXTENSION SCHEMA	avnr-20120331.xsd	EX-101.SCH	13136
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	avnr-20120331_cal.xml	EX-101.CAL	31681
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	avnr-20120331_lab.xml	EX-101.LAB	115143
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	avnr-20120331_pre.xml	EX-101.PRE	67265

Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656

Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700

AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)